FRANCE –CardioRenal, a Grenoble-based company that specializes in improving the treatment of patients with severe chronic renal disease (CKD) at home, has raised US$3.7 million in seed funding. The backers…
Read MoreCardioRenal raises US$3.7 million in seed funding
